Literature DB >> 16443905

Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.

Matthew C Riddle1, Daniel J Drucker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16443905     DOI： 10.2337/diacare.29.02.06.dc05-1267

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

Review 1.  The role of gut hormones in glucose homeostasis.

Authors:  Daniel J Drucker
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 2.  Pharmacotherapy for obesity.

Authors:  Lisa M Neff; Louis J Aronne
Journal:  Curr Atheroscler Rep       Date:  2007-12       Impact factor: 5.113

Review 3.  New targets to treat obesity and the metabolic syndrome.

Authors:  Kathleen A Martin; Mitra V Mani; Arya Mani
Journal:  Eur J Pharmacol       Date:  2015-05-19       Impact factor: 4.432

Review 4.  Islet α cells and glucagon--critical regulators of energy homeostasis.

Authors:  Jonathan E Campbell; Daniel J Drucker
Journal:  Nat Rev Endocrinol       Date:  2015-04-07       Impact factor: 43.330

Review 5.  GLP-1 and Amylin in the Treatment of Obesity.

Authors:  T Jorsal; J Rungby; F K Knop; T Vilsbøll
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

Review 6.  How do different GLP-1 mimetics differ in their actions?

Authors:  Simeon Pierre Choukem; Jean-François Gautier
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 7.  Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications.

Authors:  Satomi Onoue; Shingen Misaka; Shizuo Yamada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

8.  Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period.

Authors:  Aoife M Brennan; Laura L Sweeney; Xiaowen Liu; Christos S Mantzoros
Journal:  Obesity (Silver Spring)       Date:  2009-11-12       Impact factor: 5.002

9.  Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.

Authors:  Juan Pablo Maianti; Amanda McFedries; Zachariah H Foda; Ralph E Kleiner; Xiu Quan Du; Malcolm A Leissring; Wei-Jen Tang; Maureen J Charron; Markus A Seeliger; Alan Saghatelian; David R Liu
Journal:  Nature       Date:  2014-05-21       Impact factor: 49.962

10.  The potential role of vildagliptin in the management and prevention of type 2 diabetes mellitus.

Authors:  C K Chakraborti
Journal:  Indian J Pharmacol       Date:  2008-01       Impact factor: 1.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.